WELL Health Technologies
Financials
Estimates*
CAD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 50.2m | 302m | 569m | 776m | 957m | 1.0b | 1.1b |
% growth | 53 % | 502 % | 88 % | 36 % | 23 % | 8 % | 5 % |
EBITDA | (5.6m) | 32.0m | 77.3m | 89.5m | 128m | 150m | 179m |
% EBITDA margin | (11 %) | 11 % | 14 % | 12 % | 13 % | 14 % | 16 % |
Profit | (3.7m) | (43.8m) | 1.4m | <1m | 126m | 5.0m | 25.0m |
% profit margin | (7 %) | (14 %) | - | - | 13 % | - | 2 % |
EV / revenue | 26.0x | 4.3x | 1.6x | 1.6x | 1.5x | 1.3x | 1.2x |
EV / EBITDA | -232.3x | 40.5x | 11.6x | 13.8x | 11.1x | 8.8x | 7.3x |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | CAD10.5m | Post IPO Debt | |
N/A | CAD11.0m | Post IPO Debt | |
N/A | CAD23.0m | Post IPO Equity | |
N/A | CAD70.0m | Post IPO Debt | |
* | N/A | $34.5m | Post IPO Equity |
Total Funding | - |
Related Content
Recent News about WELL Health Technologies
EditWELL Health Technologies Corp. is a digital health company focused on modernizing and improving primary healthcare experiences in Canada. The company leverages technology to empower and support both patients and doctors, aiming to positively impact health outcomes. WELL serves a diverse range of clients including healthcare providers, clinics, and patients, operating primarily in the digital health market. Its business model includes providing virtual care services, patient engagement technology, and eReferral software. WELL generates revenue through service fees, software subscriptions, and strategic acquisitions. The company is publicly traded on the Toronto Stock Exchange under the ticker TSX: WELL and is backed by notable investors and an experienced management team.
Keywords: digital health, primary healthcare, virtual care, patient engagement, eReferral software, technology, innovation, Canada, healthcare providers, TSX: WELL.